This official website is maintained by the Settlement Administrator retained and supervised by Class Counsel for the Settlement Class Members in the action entitled, Fund Liquidation Holdings LLC. et al. v. UBS AG et al., No. 15-cv-5844 (GBD) (S.D.N.Y.)) pending in the United States District Court for the Southern District of New York.
**IMPORTANT UPDATE**
On June 18, 2024, the Court approved the Société Générale Settlement.
The Court entered an order on February 20, 2024 preliminarily approving the proposed settlement with: Société Générale (“SocGen”) dated February 16, 2024.
The information below has been updated for this Settlement. If you have already submitted a claim in connection with any of the earlier settlements in this case, no additional claim needs to be submitted to participate in this Settlement.
On June 18, 2024, the Court approved the Société Générale Settlement.
The Court entered an order on February 20, 2024 preliminarily approving the proposed settlement with: Société Générale (“SocGen”) dated February 16, 2024.
The information below has been updated for this Settlement. If you have already submitted a claim in connection with any of the earlier settlements in this case, no additional claim needs to be submitted to participate in this Settlement.
The information contained on this web page is only a summary of information presented in more detail in the Notice of Proposed Class Action Settlement, June 18, 2024 Fairness Hearing Thereon, and
Class Members’ Rights (the “Notice”), which you can access by clicking here. Since this website is just a summary, you should review the Notice and Settlement
Agreement for additional details.
Your Legal Rights Could Be Affected Whether You Act Or Do Not Act. Please Read The Notice Carefully.
IF YOU TRANSACTED EUROYEN-BASED DERIVATIVES BETWEEN JANUARY 1, 2006 THROUGH JUNE 30, 2011, INCLUSIVE, (THE “CLASS PERIOD”), YOU MAY BE ENTITLED TO A PAYMENT FROM A CLASS ACTION SETTLEMENT.
| IMPORTANT DATES AND DEADLINES | |
|---|---|
| SUBMIT A PROOF OF CLAIM |
To be eligible for a payment from the Net Settlement Fund a Claim Form must be postmarked no later than August 2, 2024. Note, if you already timely submitted a valid proof of claim and release pursuant to the 2016 Notice, 2017 Notice, 2018 Notice, 2019 Notice, or 2022 Notice, you DO NOT need to submit a new Proof of Claim and Release to participate in this Settlement. If you did not file a Claim Form with the previous settlements, and if you do not file a Claim Form by, August 2, 2024, you will not be eligible to receive any money from the Settlement Fund. |
| EXCLUDE YOURSELF FROM THE SETTLEMENT CLASS FOR THE SETTLEMENT | If you do not wish to be bound by the terms of the SocGen Settlement, you must submit a written request for exclusion postmarked no later than May 20, 2024. |
| OBJECT TO THE SETTLEMENT | Any objections to the proposed Settlement must be filed no later than May 20, 2024. |
| SETTLEMENT HEARING |
A hearing will be held on June 18, 2024 at 10:00 am at the United States District Court Southern District of New York, Courtroom 11A, to consider the fairness, reasonableness,
and adequacy of the Settlement. Anyone wishing to attend the Settlement Hearing must include a written notice of the intention to appear with their Objection, and filed, no later than May 20, 2024. |
Any change by the Court of the Plan of Allocation, the time and place of the Fairness Hearing, or any other matter and all further orders or requirements by the Court will be posted on this website as
soon as practicable.
It is important that you refer to this website as no other notice may be published of such changes.
What is this case about?
Representative Plaintiffs allege that each Defendant, from January 1, 2006 through June 30, 2011, inclusive, manipulated or aided and abetted the manipulation of Yen-LIBOR, Euroyen TIBOR, and the prices of Euroyen-Based Derivatives. Defendants allegedly did so by using several means of manipulation. For example, panel banks that made the daily Yen-LIBOR and/or Euroyen TIBOR submissions to the British Bankers’ Association and Japanese Bankers’ Association (the “Contributor Bank Defendants”), allegedly falsely reported their cost of borrowing to financially benefit their Euroyen-Based Derivatives positions. Contributor Bank Defendants also allegedly requested that other Contributor Bank Defendants make false Yen-LIBOR and Euroyen TIBOR submissions on their behalf to benefit their Euroyen-Based Derivatives positions and used inter-dealer brokers, intermediaries between buyers and sellers in the money markets and derivatives markets, to manipulate Yen-LIBOR, Euroyen TIBOR, and the prices of Euroyen-Based Derivatives by disseminating false “Suggested LIBORs,” publishing false market rates on broker screens, and publishing false bids and offers into the market.
Plaintiffs have asserted legal claims under various theories, including federal antitrust law, the Commodity Exchange Act (“CEA”), the Racketeering Influenced and Corrupt Organizations (“RICO”) Act, and common law.
SocGen has consistently and vigorously denied Representative Plaintiffs’ allegations. SocGen entered into a Settlement Agreement with Representative Plaintiffs, despite believing that it is not liable for the claims asserted against it, to avoid the further expense, inconvenience, and distraction of burdensome and protracted litigation, thereby putting this controversy to rest and avoiding the risks inherent in complex litigation.
What is a Euroyen-Based Derivative?
“Euroyen-Based Derivatives” means (i) a Euroyen TIBOR futures contract on the Chicago Mercantile Exchange (“CME”); (ii) a Euroyen TIBOR futures contract on the Tokyo Financial Exchange, Inc. (“TFX”), Singapore Exchange (“SGX”), or London International Financial Futures and Options Exchange (“LIFFE”) entered into by a U.S. Person, or by a Person from or through a location within the U.S.; (iii) a Japanese Yen currency futures contract on the CME; (iv) a Yen-LIBOR and/or Euroyen TIBOR based interest rate swap entered into by a U.S. Person, or by a Person from or through a location within the U.S.; (v) an option on a Yen-LIBOR and/or Euroyen TIBOR based interest rate swap (“swaption”) entered into by a U.S. Person, or by a Person from or through a location within the U.S.; (vi) a Japanese Yen currency forward agreement entered into by a U.S. Person, or by a Person from or through a location within the U.S.; and/or (vii) a Yen-LIBOR and/or Euroyen TIBOR based forward rate agreement entered into by a U.S. Person, or by a Person from or through a location within the U.S.
It is important that you refer to this website as no other notice may be published of such changes.
What is this case about?
Representative Plaintiffs allege that each Defendant, from January 1, 2006 through June 30, 2011, inclusive, manipulated or aided and abetted the manipulation of Yen-LIBOR, Euroyen TIBOR, and the prices of Euroyen-Based Derivatives. Defendants allegedly did so by using several means of manipulation. For example, panel banks that made the daily Yen-LIBOR and/or Euroyen TIBOR submissions to the British Bankers’ Association and Japanese Bankers’ Association (the “Contributor Bank Defendants”), allegedly falsely reported their cost of borrowing to financially benefit their Euroyen-Based Derivatives positions. Contributor Bank Defendants also allegedly requested that other Contributor Bank Defendants make false Yen-LIBOR and Euroyen TIBOR submissions on their behalf to benefit their Euroyen-Based Derivatives positions and used inter-dealer brokers, intermediaries between buyers and sellers in the money markets and derivatives markets, to manipulate Yen-LIBOR, Euroyen TIBOR, and the prices of Euroyen-Based Derivatives by disseminating false “Suggested LIBORs,” publishing false market rates on broker screens, and publishing false bids and offers into the market.
Plaintiffs have asserted legal claims under various theories, including federal antitrust law, the Commodity Exchange Act (“CEA”), the Racketeering Influenced and Corrupt Organizations (“RICO”) Act, and common law.
SocGen has consistently and vigorously denied Representative Plaintiffs’ allegations. SocGen entered into a Settlement Agreement with Representative Plaintiffs, despite believing that it is not liable for the claims asserted against it, to avoid the further expense, inconvenience, and distraction of burdensome and protracted litigation, thereby putting this controversy to rest and avoiding the risks inherent in complex litigation.
What is a Euroyen-Based Derivative?
“Euroyen-Based Derivatives” means (i) a Euroyen TIBOR futures contract on the Chicago Mercantile Exchange (“CME”); (ii) a Euroyen TIBOR futures contract on the Tokyo Financial Exchange, Inc. (“TFX”), Singapore Exchange (“SGX”), or London International Financial Futures and Options Exchange (“LIFFE”) entered into by a U.S. Person, or by a Person from or through a location within the U.S.; (iii) a Japanese Yen currency futures contract on the CME; (iv) a Yen-LIBOR and/or Euroyen TIBOR based interest rate swap entered into by a U.S. Person, or by a Person from or through a location within the U.S.; (v) an option on a Yen-LIBOR and/or Euroyen TIBOR based interest rate swap (“swaption”) entered into by a U.S. Person, or by a Person from or through a location within the U.S.; (vi) a Japanese Yen currency forward agreement entered into by a U.S. Person, or by a Person from or through a location within the U.S.; and/or (vii) a Yen-LIBOR and/or Euroyen TIBOR based forward rate agreement entered into by a U.S. Person, or by a Person from or through a location within the U.S.
Commodities Brokers and other Nominees: Please visit the
Institutional E-Filing page of this website.
If you have questions, you may call the Euroyen Settlement Help Line at 866-217-4453,
or email info@EuroyenSettlement.com
or email info@EuroyenSettlement.com
